Lv1
80 积分 2024-08-28 加入
New target to tackle coronaviruses
19天前
已完结
Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target
19天前
已完结
Short FcRn-Binding Peptides Enable Salvage and Transcytosis of scFv Antibody Fragments
2个月前
已完结
Clinical Pharmacology Strategies for Bispecific Antibody Development: Learnings from FDA‐Approved Bispecific Antibodies in Oncology
3个月前
已完结
A recycling program that keeps PD-L1 out of the cancer cell's junkyard
4个月前
已关闭
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
4个月前
已完结
An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
4个月前
已完结
Cancer therapy with antibodies
5个月前
已完结
An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
7个月前
已完结
A Novel Inhalable Nanobody Targeting IL-4Rα for the Treatment of Asthma
7个月前
已完结
皖公网安备34019202002308
